Yesterday, the Minnesota Department of Health approved adding Alzheimer’s disease as a qualifying condition for medical cannabis, but rejected opioid use disorder, hepatitis C, traumatic brain injury, and insomnia.
Many thanks to Sensible Minnesota and to all the advocates and health professionals who were involved in petitioning to expand the program! Their dedicated work (with an assist from MPP) also resulted in the addition of intractable pain, PTSD, autism, and sleep apnea.
Under state law, Alzheimer’s disease patients will be able to apply for medical cannabis starting next summer.
Georgians suffering from post-traumatic stress disorder (PTSD) and those with intractable pain may begin signing up for the state’s low-THC oil program. A bill passed earlier this year, House Bill 65, went into effect on July 1, adding these two serious conditions.
Intractable pain is devastating and is often defined as constant and excruciating. Those who experience it sometimes turn to reliance on opioid medications. While low-THC oil may not replace opioids for these patients, many have found medical cannabis products can allow them to use fewer opioids by reducing pain levels, helping patients maintain appetite and serving as a sleep aid. It can be an important new tool in a treatment program.
Many who suffer from PTSD can also find relief through use of medical cannabis products. This debilitating disease can affect all aspects of a person’s life, and like intractable pain, pharmaceutical drugs used to treat the condition can themselves cause harm. Veterans and those experiencing PTSD deserve a safer alternative.
The state’s program has grown in recent years, but Georgia’s limited, low-THC approach remains flawed. While patients have some protections, there is no regulatory system behind production or sale, leaving access to cannabis in the shadows. We hope Georgia can improve its program when lawmakers reconvene in 2019.
While short of a complete solution, these changes are welcome.
Gov. John Bel Edwards has signed HB 579 and HB 627, which expand the qualifying conditions for medical marijuana! These two bills add a variety of new conditions including autism, PTSD, and intractable pain.
This is a great step towards Louisiana having a functional medical marijuana program. Next session, we are hopeful the legislature will allow the vaporization of medical marijuana so that patients can finally have real access to the medicine they need.
Congratulations to Sensible Marijuana Policy for Louisiana and all the activists that showed up to the statehouse and contacted their lawmakers in support of these reforms!
The Iowa Senate Appropriations Committee introduced a bill to establish a comprehensive medical cannabis program in the state. The bill already received unanimous support by a subcommittee at a hearing last week, and may receive a full Senate vote as early as this week.
The bill would allow patients suffering from cancer, PTSD, intractable pain, and a host of other aliments access to this life-saving treatment option if their doctors certify them for the program. The bill would not allow patients to smoke cannabis, but patients could still vaporize or consume their medicine in other forms. You can read more about the bill here.
The Iowa legislative session is almost over for the year, so in order to pass this bill, your lawmakers need to hear from you. If you are an Iowa resident, please contact your legislators.
Virginia is in its final week of its 2016 legislative session and of the many marijuana-related bills Virginian lawmakers considered this year, only one — SB 701 — has made it to the desk of Gov. Terry McAuliffe.
This limited bill allows the cultivation of cannabis by pharmaceutical processes that would then produce cannabidiol oil. Patients suffering from intractable epilepsy could receive the oil with a written certification from their doctor. While Gov. McAuliffe is expected to sign the legislation, epileptic patients won’t receive any benefit until at least 2017, as the bill requires a second passage next year.
While MPP applauds the Commonwealth’s effort to bring relief to residents suffering from epilepsy, this measure does not go nearly far enough. If you are a resident of Virginia, please ask your elected officials to show compassion for our sickest residents, including those with other serious conditions, such as multiple sclerosis, intractable pain, and PTSD. Medical marijuana is far less harmful and poses fewer negative side effects than most prescription drugs — especially painkillers — and patients often find it to be a more effective treatment.
We celebrate this narrow victory and look forward to a future where patients can benefit from the expertise of their doctors by finding relief in medical cannabis.
Minnesota Department of Health Commissioner Ed Ehlinger gave patients reason to cheer earlier this month when he approved intractable pain as a qualifying condition for medical marijuana. Unfortunately, though, proposed revisions to Minnesota’s medical marijuana regulations could result in an excruciatingly long delay for reviewing future petitions. Under the proposed changes, there could be a delay of more than two years from the time a petition to add a new qualifying condition or delivery method is made to when it takes effect!
If you are a Minnesota resident, please write to Commissioner Ed Ehlinger at the Minnesota Department of Health and urge him to once again show compassion to patients by changing the timeline for adding new conditions. Members of the public may comment on the proposed rules until Wednesday, December 16.
A vast majority of medical marijuana states allow individuals to use and access any number of preparations of medical marijuana to treat a variety of conditions. Minnesota is one of the few that exclude conditions like severe nausea and that strictly limits the modes of delivery — including by excluding whole plant.
Unless the legislature passes a measure to override his compassionate decision, patients with intractable pain can be certified under the program beginning July 1, 2016. Once certified, they can receive medical marijuana beginning August 1, 2016.
A vast majority of medical marijuana states allow individuals to use and access medical marijuana to treat severe pain, and Minnesota does well to follow suit. Cannabis is far safer than opioids and prescription painkillers, and patients deserve this option.
The Minnesota Office of Medical Cannabis Advisory Panel on Intractable Pain will meet on Thursday to decide if intractable pain should be added to the list of qualifying medical conditions under the state’s medical marijuana law. While the public is welcome to attend the meeting, please note that public comment will not be taken on Thursday.
WHAT: Advisory Panel on Intractable Pain meeting
WHEN: Thursday, October 29, 1:00 - 3:00 p.m. CT
WHERE: Amherst H. Wilder Center — Auditorium A, St. Paul
For the past two months, the Minnesota Department of Health has been hosting meetings across the state to solicit public feedback on whether intractable pain should be added. Reports indicate an overwhelming majority of attendees supported adding pain. They also accepted written comments from potential and certified medical cannabis patients, their caregivers and loved ones, health care practitioners, and other interested parties. Just this past weekend, the Star Tribune published an editorial urging the Department of Health to add intractable pain to the state’s medical marijuana law.
Thank you so much to everyone who attended the community hearings, submitted comments, and urged your friends and family to do so, too. These simple acts may soon mean a world of difference for some suffering neighbors.
The Medical Cannabis Advisory Board agreed last week to recommend adding eight new medical conditions to Illinois’ medical cannabis pilot program. The conditions are chronic pain syndrome, autism, osteoarthritis, post-traumatic stress disorder, chronic pain due to trauma, chronic post-operative pain, intractable pain, and irritable bowel syndrome.
The department previously rejected the advisory board’s recommendation that it approve 11 conditions. At the time it noted that the program was not yet fully up and running, but now with at least one dispensary opening this month, that reasoning no longer applies. Just yesterday, Harbory in Marion, Illinois became the first dispensary to open in the state.
These changes would significantly improve the state program. The medical cannabis program recognizes only a narrow range of conditions, and Illinois is in the minority of medical marijuana states when it comes to options for patients with serious pain. In addition, an increasing number of medical marijuana states recognize post-traumatic stress disorder (PTSD). Seriously ill patients in Illinois should not be left behind. The state should listen to its team of experts and adopt these conditions without delay.
Earlier this year, the Minnesota Legislature approved a bill requiring the state’s Department of Health to recommend by January 1, 2016, whether intractable pain should be added as a condition that qualifies for medical cannabis. The department is currently seeking public input on this question and has created two opportunities to share your thoughts.
First, the department is accepting written comment on including intractable pain. There is currently no deadline for submitting comments. However, potential patients, their caregivers, and supportive health care practitioners should submit their comments soon so they can be taken into consideration early in the process.
Second, the department will be hosting listening sessions around the state to take public testimony on including intractable pain. The first two will be held this week:
Wednesday, August 26 from 5:30 p.m. to 7:30 p.m. at the Rochester Public Library
Thursday, August 27 from 5:30 p.m. to 7:30 p.m. at the Kandiyohi Health and Human Services building in Willmar, Minnesota
Additional events will be held across the state in September and October. We will let you know when and where they will be closer to the date.
More than 15,000 Americans die each year from prescription opiate overdoses. Patients deserve a safer — and often more effective — alternative. Please check out our talking points and let the department know it’s time to stop leaving intractable pain patients behind.